Physician profile
Michael Rosselli
NPI 1083851356
$1,368.68
in general payments reported to CMS, 2019-2025
15 companies · $24.01 in 2025
The $24.01 reported for 2025 was less than what a typical Sports Medicine (Emergency Medicine) provider received nationally (typical 2025 total: $100).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $166 · 2021: $239 · 2022: $314 · 2023: $99.54 · 2024: $48.07 · 2025: $24.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $393.40 | 2021-2024 | Dalvance |
| Allergan, INC. | $244.34 | 2019-2020 | |
| Bioventus LLC | $183.53 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Janssen Pharmaceuticals, INC | $116.43 | 2019-2021 | |
| Depuy Synthes Sales INC. | $113.04 | 2019-2024 | Monovisc, Orthovisc |
| Csl Behring | $103.67 | 2019-2022 | |
| Pacira Therapeutics, INC. | $55.27 | 2019-2020 | |
| Pfizer INC. | $33.77 | 2022-2023 | |
| Endo Pharmaceuticals INC. | $23.15 | 2022 | |
| Electronic Waveform Lab, INC. | $21.09 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.14 | 2023 | Iovera, Zilretta |
| Si-Bone, INC. | $18.28 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $16.07 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $14.92 | 2019 | |
| Fidia Pharma USA INC. | $12.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rosselli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.